Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...
New research demonstrates that The Self-Administered Gerocognitive Exam (SAGE) can do exactly that. Here's everything you ...
An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...
In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...
MONDAY, Sept. 30, 2024 (HealthDay News) -- A synthetic form of the active ingredient in cannabis helps reduce agitation in ...